Laninamivir
Laninamivir (R 125489) is a potent influenza neuraminidase (NA) inhibitor with IC50s of 0.90 nM, 1.83 nM and 3.12 nM for avian H12N5 NA (N5), pH1N1 N1 NA (p09N1) and A/RI/5+/1957 H2N2 N2 (p57N2), respectively[1].
Product Specifications
CAS Number
203120-17-6
Product Name Alternative
R 125489
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Influenza Virus
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/laninamivir.html
Purity
99.97
Solubility
H2O : 5 mg/mL (ultrasonic)
Smiles
OC[C@@H](O)[C@H]([C@@]1([H])[C@@H]([C@H](C=C(C(O)=O)O1)NC(N)=N)NC(C)=O)OC
Molecular Formula
C13H22N4O7
Molecular Weight
346.34
Precautions
H302, H315, H319, H335
References & Citations
[1]Vavricka CJ, et al. Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition. PLoS Pathog. 2011 Oct;7 (10) :e1002249.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-61110R-PerCP-01 20 µL
PHD1 Recombinant Antibody, PerCP Conjugated
Sign In for Pricing
View Details bsm-61110R-PerCP-02 100 µL
PHD1 Recombinant Antibody, PerCP Conjugated
Sign In for Pricing
View Details 
